Sabrina S. Harmouch
Papers
1
Total Citations
5
H-Index
1
About
Dr. Sabrina S. Harmouch is a prominent urological pathologist whose research centers on refining prostate cancer grading and prognostication. Her most impactful work involves the external validation of the novel International Society of Urological Pathology (ISUP) Gleason grading groups, a landmark study published in 2018 that has garnered 5 citations. In this pivotal contribution, Dr. Harmouch and her colleagues tested the discriminatory ability of the 2014 ISUP grading system for predicting biochemical recurrence after robot-assisted radical prostatectomy in a large, contemporary Canadian cohort. By demonstrating the system’s clinical utility, her work has helped standardize prostate cancer grading worldwide, directly influencing treatment decisions and patient counseling. Beyond this, her research portfolio encompasses the intersection of pathology and surgical outcomes, with a focus on improving risk stratification for men with prostate cancer. Dr. Harmouch’s contributions have been recognized as essential to bridging the gap between histopathological classification and real-world clinical practice, making her a key figure in advancing precision medicine in urological oncology.
Research Focus
Key Achievements
Top Papers
- 1